Rosa’s lab has demonstrated that DUX4 functions as a co-repressor of progesterone and glucocorticoid nuclear receptors [158], a phenomenon that may contribute to the sex differences observed in the onset and severity of FSHD [6]. The gene discussed is DUX4; the disease is facioscapulohumeral muscular dystrophy.